On Wednesday, October 8, we proudly celebrated the official launch of the IPRD Viral Vector & Gene Editing Core  Florida State University College of Medicine.

The event featured an overview and networking reception with Dr. Boris Kantor, Director of the Core, and Dr. Leanne Duke, Postdoctoral Research Associate. IPRD Director Dr. Pradeep Bhide noted, “Dr. Kantor’s leadership and expertise are helping IPRD build a powerful new capability for next-generation gene therapy research at FSU.”

What We Offer:

1. AAV, retroviral, and lentiviral vector design & packaging with multiple serotypes/pseudotypes
2. CRISPR/Cas9 genome, epigenome, base, and prime editing
3. Fast turnaround (as fast as 7 days) from midiprep to virus
4. Proprietary technologies, expert consultation, flexible options, and researcher-friendly pricing

We add value to your research—every step of the way.
 

Visit our Viral Vector and Gene Editing Core page